Mind Medicine (MindMed) Inc. (MNMD)
After hours:
Chart Events
Performance Outlook
| Previous Close | 3.0700 |
| Open | 3.0800 |
| Bid | 3.1500 x 800 |
| Ask | 3.1900 x 900 |
| Day's Range | 3.0800 - 3.1900 |
| 52 Week Range | 2.1200 - 19.9500 |
| Volume | |
| Avg. Volume | 507,980 |
| Market Cap | 120.661M |
| Beta (5Y Monthly) | 2.20 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.8800 |
| Earnings Date | May 15, 2023 - May 19, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 22.63 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for MNMD
Related Research
- Mind Medicine (MindMed) Inc.Analyst Report: UWM Holdings CorporationBased in Pontiac, Michigan, UWM Holdings Corp. is a wholesale mortgage originator that focuses on broker services rather than direct-to-consumer loans. It generates revenue from three segments: loan production, loan servicing, and interest income. UWMC is the leading wholesale mortgage lender in the U.S., with a roughly 54% share of the wholesale market, and acts as a conduit for mortgage brokers in all 50 states. The company has 8,000 employees.RatingFair ValueEconomic Moat27 days agoArgus Research
- Business Wire
MindMed Reports Full Year 2022 Financial Results and Business Highlights
NEW YORK, March 09, 2023--Mind Medicine (MindMed) Inc. today reported its financial results for the full-year ended December 31, 2022.
- Business Wire
MindMed to Participate in March Investor Conferences
NEW YORK, February 28, 2023--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company's management team will participate in the following investor conferences:
- Exec Edge
Nasdaq Gets a Healthy Dose of Psychedelics With Lucy Scientific
By Exec Edge Editorial Staff Lucy Scientific Discovery Inc. (Nasdaq: LSDI), which focuses on psychotropic drugs and had its initial public offering last week, rang the closing bell at the Nasdaq stock exchange today in New York. The company is focused on becoming the premier research, development, and manufacturing organization for the emerging psychedelics-based medicines […]
